Characterizing metabolic changes in human colorectal cancer

Michael D. Williams, Xing Zhang, Jeong Jin Park, William F. Siems, David R. Gang, Linda M.S. Resar, Raymond Reeves, Herbert H. Hill

Research output: Contribution to journalArticlepeer-review

Abstract

Abstract Colorectal cancer (CRC) remains a leading cause of cancer death worldwide, despite the fact that it is a curable disease when diagnosed early. The development of new screening methods to aid in early diagnosis or identify precursor lesions at risk for progressing to CRC will be vital to improving the survival rate of individuals predisposed to CRC. Metabolomics is an advancing area that has recently seen numerous applications to the field of cancer research. Altered metabolism has been studied for many years as a means to understand and characterize cancer. However, further work is required to establish standard procedures and improve our ability to identify distinct metabolomic profiles that can be used to diagnose CRC or predict disease progression. The present study demonstrates the use of direct infusion traveling wave ion mobility mass spectrometry to distinguish metabolic profiles from CRC samples and matched non-neoplastic epithelium as well as metastatic and primary tumors at different stages of disease (T1-T4). By directly infusing our samples, the analysis time was reduced significantly, thus increasing the speed and efficiency of this method compared to traditional metabolomics platforms. Partial least squares discriminant analysis was used to visualize differences between the metabolic profiles of sample types and to identify the specific m/z features that led to this differentiation. Identification of the distinct m/z features was made using the human metabolome database. We discovered alterations in fatty acid biosynthesis and oxidative, glycolytic, and polyamine pathways that distinguish tumors from non-malignant colonic epithelium as well as various stages of CRC. Although further studies are needed, our results indicate that colonic epithelial cells undergo metabolic reprogramming during their evolution to CRC, and the distinct metabolites could serve as diagnostic tools or potential targets in therapy or primary prevention. [Figure not available: see fulltext.]

Original languageEnglish (US)
Article number8662
Pages (from-to)4581-4595
Number of pages15
JournalAnalytical and Bioanalytical Chemistry
Volume407
Issue number16
DOIs
StatePublished - Jun 28 2015

Keywords

  • Bioanalytical methods
  • Cancer biomarkers
  • Colorectal cancer
  • Ion mobility mass spectrometry
  • Mass spectrometry ICP-MS
  • Metabolomics

ASJC Scopus subject areas

  • Analytical Chemistry
  • Biochemistry

Fingerprint Dive into the research topics of 'Characterizing metabolic changes in human colorectal cancer'. Together they form a unique fingerprint.

Cite this